(Q68838039)
Statements
Chemotherapy subsequent to recombinant interleukin-2 immunotherapy: protocol for enhanced tumoricidal activity (English)
Ades EW
McKemie CR 3rd
Wright S
Peacocke N
Pantazis C
Lockhart WL 3rd
1 January 1987